ACTRN12612001288819招募中未知
For obese people with fatty liver, dose Yin-Chen-Hao-Tang has effect on fatty liver degree?
Taoyuan Chang Gung Memorial Hospital of The Chang Gung Medical Fundation0 个研究点目标入组 20 人开始时间: 2012年12月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 20 Years 至 65 Years(—)
- 性别
- All
入选标准
- •participant who is obese with fatty liver that is diagnosed at outpatient department
排除标准
- •1.Patient has ALT and AST levels of over 1000 u/L
- •2.Patient has a-Fetoprotein (AFP) levels of over 2 upper laboratory norms.
- •3.Patient is pregnant
- •4.Patients with alcoholic or drug abuse
- •5.Patients treatment with drugs, e.g. corticosteroids, high-dose estrogens, methotrexate, amiodarone, calcium channel blockers, spironolactone, sulfasalazine, naproxen, or oxacillin.
- •6.Patient has total cholesterol (TC) and triglyceride (TG) over 300 u/L
- •7.Patient has fast plasma glucose over 126 mg/dl, and postprandial plasma glucose over 200mg/dl
- •8.Patient has HBsAg positive
- •9.Patient has Anti-HCV positive
- •10.Patient with a malignancy which can influence prognosis
- •11.Patient has BP less than 90/50 mm/Hg
研究者
相似试验
尚未招募
不适用
on-alcoholic Fatty Liver Disease Dietary TrialACTRN12612000841875Catherine Properzi66
招募中
不适用
Effects of obesity, non-alcoholic fatty liver disease and bariatric surgery on systemic cytochrome P450-mediated drug metabolism using a COCKTAIL approach.NL-OMON50513Academisch Medisch Centrum17
已完成
不适用
Response of metabolic parameters to 4 weeks of High Intensity Interval Training (HIIT)Type 2 diabetes.Type 2 diabetesIRCT20200729048246N1Shahid Beheshti University of Medical Sciences70
已完成
不适用
The Effect of Curcumin on Liver Fat Content in Obese SubjectsNon-Alcoholic Fatty Liver DiseaseGlucose Tolerance ImpairedObesity, AbdominalInsulin ResistanceNCT03864783Steno Diabetes Center Copenhagen39
已完成
不适用
Resolution of Liver Fat in Non-alcoholic Fatty Liver DiseaseNAFLDNCT02558530Helsinki University Central Hospital20
